Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wise

Showing results (301-310 of 361) with videos related to

Pageof 37
Sort By:
British Journal of Clinical Pharmacology|October 10, 2007
Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR inhaled insulin pharmacokinetics and glucodynamicsAlan X Pan, Amparo de la Peña, Kwee P Yeo, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomersH A DeWald, T G Heffner, J C Jaen, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 1995
Development and submission of a nonclinical (pharmacology/toxicology) CANDAJ B Coleman, L D Wise, W P Greenberg, et al.
Journal of Medicinal Chemistry|June 6, 1997
Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonistsS A Glase, H C Akunne, L M Georgic, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effectsL T Meltzer, C L Christoffersen, A E Corbin, et al.
Teratology|July 1, 1990
External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitorR L Clark, J M Antonello, S J Grossman, et al.
Psychiatry Research|February 1, 1981
A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patientsL E DeLisi, C D Wise, T P Bridge, et al.
Journal of Medicinal Chemistry|December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2002
The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonistsThomas A Pugsley, Yu Hsin Shih, Steven Z Whetzel, et al.
Pageof 37

Showing results (301-310 of 361) with videos related to

Sort By:
Pageof 37
British Journal of Clinical Pharmacology|October 10, 2007
Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR inhaled insulin pharmacokinetics and glucodynamicsAlan X Pan, Amparo de la Peña, Kwee P Yeo, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomersH A DeWald, T G Heffner, J C Jaen, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 1995
Development and submission of a nonclinical (pharmacology/toxicology) CANDAJ B Coleman, L D Wise, W P Greenberg, et al.
Journal of Medicinal Chemistry|June 6, 1997
Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonistsS A Glase, H C Akunne, L M Georgic, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effectsL T Meltzer, C L Christoffersen, A E Corbin, et al.
Teratology|July 1, 1990
External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitorR L Clark, J M Antonello, S J Grossman, et al.
Psychiatry Research|February 1, 1981
A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patientsL E DeLisi, C D Wise, T P Bridge, et al.
Journal of Medicinal Chemistry|December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2002
The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonistsThomas A Pugsley, Yu Hsin Shih, Steven Z Whetzel, et al.
Pageof 37